Morepen Laboratories Limited — Updates, 23-02-2026: Press Release
23-02-2026 | 09:02 am
23-02-2026 | 09:02 am
Morepen Laboratories secured a multi-year global CDMO mandate valued at ₹825 Cr (USD 91 million), expanding into the high-growth CDMO segment. Supplies are expected to commence in 4-5 months, executing through Q1 of the next financial year, marking a significant strategic expansion.
No comments yet. Be the first to comment!
